Precigen Ownership | Who Owns Precigen?
Precigen Ownership Summary
Precigen is owned by 12.63% institutional investors, 9.93% insiders, and 77.45% retail investors. Patient capital management is the largest institutional shareholder, holding 6.48% of PGEN shares. Patient Opportunity C is the top mutual fund, with 4.92% of its assets in Precigen shares.
PGEN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Precigen | 12.63% | 9.93% | 77.45% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Patient capital management | 17.88M | 6.48% | $20.03M |
Blackrock | 10.25M | 4.11% | $16.19M |
Adage capital partners gp | 10.87M | 3.94% | $12.17M |
Blackrock funding, inc. /de | 10.38M | 3.76% | $11.62M |
Vanguard group | 8.33M | 3.02% | $9.33M |
Iridian asset management llc/ct | 5.24M | 1.90% | $5.87M |
Geode capital management | 3.30M | 1.20% | $3.70M |
State street | 2.84M | 1.14% | $4.49M |
Charles schwab investment management | 1.28M | 0.46% | $1.43M |
Northern trust | 1.03M | 0.41% | $1.63M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Iridian asset management llc/ct | 5.24M | 1.56% | $5.87M |
Patient capital management | 17.88M | 0.92% | $20.03M |
Emfo | 519.48K | 0.73% | $820.77K |
Fore capital | 391.81K | 0.17% | $438.83K |
Lexaurum advisors | 691.54K | 0.15% | $774.53K |
Clarivest asset management | 492.15K | 0.08% | $777.60K |
Rpo | 42.14K | 0.04% | $47.20K |
Gmt capital | 668.83K | 0.04% | $749.09K |
American financial group | 66.11K | 0.03% | $74.05K |
Stoneridge investment partners | 68.68K | 0.03% | $77.00K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Iridian asset management llc/ct | 5.24M | 1.56% | 1.47M |
Susquehanna group, llp | 704.89K | 0.00% | 655.11K |
Lexaurum advisors | 691.54K | 0.15% | 417.06K |
Ubs group | 421.24K | 0.00% | 321.72K |
Cary street partners financial | 87.59K | 0.00% | 87.59K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Opaleye management | - | - | -947.50K |
D. e. shaw | 424.90K | 0.00% | -792.73K |
Renaissance | 1.07M | 0.00% | -532.54K |
Tang capital management | - | - | -500.00K |
Sanders morris harris | - | - | -363.18K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Cary street partners financial | 87.59K | 0.00% | 87.59K | $98.10K |
Xtx topco | 77.61K | 0.01% | 77.61K | $86.92K |
Group one trading | 68.86K | 0.00% | 68.86K | $77.12M |
Allegheny financial group | 54.13K | 0.02% | 54.13K | $60.63K |
Rpo | 42.14K | 0.04% | 42.14K | $47.20K |
Sold Out
Holder | Change |
---|---|
Capital performance advisors llp | -2.00 |
Farther finance advisors | -78.00 |
Creekmur asset management | -98.00 |
Innealta capital | -99.00 |
Harbor investment advisory | -125.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 69 | -47.73% | 34,834,421 | -53.82% | 12 | 1.41% | 32 | -40.74% | 13 | -58.06% |
Sep 30, 2024 | 132 | -2.22% | 75,430,370 | 24.15% | 29 | 5.16% | 54 | -6.90% | 31 | -20.51% |
Jun 30, 2024 | 133 | -0.75% | 60,750,666 | -1.85% | 24 | 3.95% | 58 | 26.09% | 39 | -15.22% |
Mar 31, 2024 | 134 | -3.60% | 61,894,662 | -1.03% | 24 | 3.80% | 46 | -13.21% | 46 | 6.98% |
Dec 31, 2023 | 139 | -2.11% | 62,537,683 | 3.31% | 25 | 4.31% | 53 | -1.85% | 43 | 10.26% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Patient Opportunity C | 14.40M | 4.92% | - |
Vanguard Total Stock Mkt Idx Inv | 5.45M | 1.85% | - |
Vanguard US Total Market Shares ETF | 5.45M | 1.85% | - |
iShares Russell 2000 ETF | 3.57M | 1.21% | -30.91K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.97M | 0.67% | 62.06K |
Fidelity Small Cap Index | 1.30M | 0.44% | -24.36K |
iShares Russell 2000 Value ETF | 1.14M | 0.39% | - |
iShares Biotechnology ETF | 1.04M | 0.35% | -11.58K |
State St Russell Sm/Mid Cp® Indx NL Cl C | 899.91K | 0.31% | - |
State St Russell Sm/Mid Cp® Indx SL Cl I | 864.21K | 0.29% | -35.70K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 30, 2024 | KIRK RANDAL J | Buy | $28.13K | |
Dec 30, 2024 | KIRK RANDAL J | Buy | $12.50M | |
Aug 09, 2024 | Perez Jeffrey Thomas | SVP, IP Affairs | Buy | $50.00K |
Aug 09, 2024 | KIRK RANDAL J | Buy | $20.00M | |
Dec 28, 2023 | KIRK RANDAL J | Buy | $136.33K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | 2 | - |
2024 Q3 | 2 | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | 1 | 1 |
PGEN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools